Inactive Instrument
AIT Therapeutics Inc Stock Other OTC
Stocks
US50027L1070
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 04-01 | Beyond Air Expands Commercial Access for LungFit® PH Through Purchasing Agreement with Top 3 National Group Purchasing Organization | CI |
| 03-26 | Beyond Air CEO Steve Lisi Resigns; COO to Succeed | MT |
| Market Cap | 6.74M 5.89M 5.41M 5.05M 9.57M 642M 9.73M 65.16M 25.25M 315M 25.32M 24.77M 1.09B | P/E 2025 |
-0.4x | P/E 2026 | -0.17x |
|---|---|---|---|---|---|
| Enterprise Value | 18.49M 16.15M 14.83M 13.83M 26.23M 1.76B 26.67M 179M 69.22M 863M 69.42M 67.91M 2.97B | EV / Sales 2025 |
7.78x | EV / Sales 2026 | 2.48x |
| Free-Float |
97.86% | Yield 2025 * |
-
| Yield 2026 | - |
Last Transcript: AIT Therapeutics Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Goodman
CEO | Chief Executive Officer | 61 | 2026-03-26 |
Daniel Moorhead
DFI | Director of Finance/CFO | 53 | 2026-01-04 |
John Jett
CTO | Chief Tech/Sci/R&D Officer | - | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Erick Lucera
BRD | Director/Board Member | 58 | 2017-08-09 |
Yoori Lee
BRD | Director/Board Member | 54 | 2018-01-01 |
William Forbes
BRD | Director/Board Member | 65 | 2018-08-12 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.49% | +2.32% | -28.86% | -12.49% | 166B | |
| +5.04% | +3.32% | -5.77% | -5.57% | 106B | |
| +2.80% | +3.33% | +1.83% | +54.09% | 57.69B | |
| +1.33% | +1.39% | +53.16% | +49.84% | 53.2B | |
| +3.39% | +4.43% | -10.83% | -40.12% | 43.56B | |
| +3.50% | +14.35% | - | - | 36.52B | |
| +3.47% | +3.79% | -14.75% | -44.56% | 27.49B | |
| +0.20% | +5.53% | +65.33% | -4.37% | 25.84B | |
| +2.78% | +3.61% | -8.42% | -3.01% | 21.27B | |
| Average | +2.89% | +4.14% | +6.46% | -0.78% | 59.8B | |
| Weighted average by Cap. | +3.31% | +3.29% | -3.68% | -0.09% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.7M 3.24M 2.97M 2.77M 5.26M 353M 5.34M 35.79M 13.87M 173M 13.91M 13.61M 596M | 7.68M 6.71M 6.16M 5.75M 10.89M 731M 11.08M 74.19M 28.75M 359M 28.83M 28.21M 1.24B |
| Net income | -46.62M -40.74M -37.41M -34.89M -66.14M -4.44B -67.26M -450M -175M -2.18B -175M -171M -7.5B | -33.25M -29.05M -26.68M -24.88M -47.17M -3.17B -47.96M -321M -124M -1.55B -125M -122M -5.35B |
| Net Debt | 4.77M 4.17M 3.83M 3.57M 6.77M 454M 6.88M 46.09M 17.86M 223M 17.91M 17.52M 768M | 11.74M 10.26M 9.42M 8.79M 16.66M 1.12B 16.94M 113M 43.97M 548M 44.09M 43.13M 1.89B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
